CME Group Inc. (NASDAQ:CME) has received an average rating of “Hold” from the thirteen research firms that are covering the firm. Two investment analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and five have given a buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $102.21.
Several brokerages have recently weighed in on CME. Zacks Investment Research upgraded CME Group from a “hold” rating to a “buy” rating and set a $116.00 price target for the company in a report on Thursday, August 4th. Jefferies Group lifted their price objective on CME Group from $112.00 to $118.00 and gave the stock a “buy” rating in a report on Wednesday, August 31st. Barclays PLC reduced their price objective on CME Group from $100.00 to $99.00 and set an “equal weight” rating for the company in a report on Friday, July 29th. JPMorgan Chase & Co. set a $116.00 price objective on CME Group and gave the stock a “buy” rating in a report on Monday, September 12th. Finally, Keefe, Bruyette & Woods lifted their price objective on CME Group from $99.00 to $103.00 and gave the stock a “market perform” rating in a report on Friday, July 29th.
In related news, CEO Phupinder Gill sold 30,002 shares of the business’s stock in a transaction that occurred on Monday, September 19th. The stock was sold at an average price of $110.00, for a total value of $3,300,220.00. Following the transaction, the chief executive officer now directly owns 116,222 shares of the company’s stock, valued at approximately $12,784,420. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Derek Sammann sold 3,550 shares of the business’s stock in a transaction that occurred on Tuesday, August 2nd. The stock was sold at an average price of $103.20, for a total value of $366,360.00. Following the completion of the transaction, the insider now directly owns 30,896 shares in the company, valued at $3,188,467.20. The disclosure for this sale can be found here. Insiders own 0.61% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Tower Research Capital LLC TRC boosted its position in CME Group by 447.6% in the second quarter. Tower Research Capital LLC TRC now owns 1,621 shares of the company’s stock worth $157,000 after buying an additional 1,325 shares in the last quarter. Parametrica Management Ltd acquired a new position in CME Group during the second quarter worth approximately $212,000. Private Advisor Group LLC acquired a new position in CME Group during the second quarter worth approximately $214,000. Ranger International Management LP acquired a new position in CME Group during the second quarter worth approximately $219,000. Finally, Evercore Wealth Management LLC boosted its position in CME Group by 19.5% in the second quarter. Evercore Wealth Management LLC now owns 2,270 shares of the company’s stock worth $221,000 after buying an additional 370 shares in the last quarter. 79.89% of the stock is currently owned by institutional investors.
Shares of CME Group (NASDAQ:CME) opened at 105.44 on Wednesday. The company has a market capitalization of $35.73 billion, a PE ratio of 26.63 and a beta of 0.83. The stock’s 50 day moving average price is $106.48 and its 200 day moving average price is $99.70. CME Group has a 12 month low of $81.87 and a 12 month high of $110.35.
CME Group (NASDAQ:CME) last issued its quarterly earnings results on Thursday, July 28th. The company reported $1.14 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.03. CME Group had a return on equity of 6.83% and a net margin of 38.22%. The firm earned $906 million during the quarter, compared to the consensus estimate of $897.84 million. During the same period last year, the company earned $0.95 earnings per share. The company’s revenue was up 10.5% on a year-over-year basis. On average, analysts forecast that CME Group will post $4.43 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Monday, September 26th. Stockholders of record on Friday, September 9th were given a dividend of $0.60 per share. The ex-dividend date was Wednesday, September 7th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 2.28%. CME Group’s payout ratio is currently 60.61%.
CME Group Company Profile
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.